A study of amsalog (CI-921) administered orally on a 5-day schedule, with bioavailability and pharmacokinetically guided dose escalation D. Fyfe F. Raynaud J. Carmichael Original Article Pages: 1 - 6
Pharmacokinetics, tissue distribution, and metabolism of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (NSC 707545) in CD2F1 mice and Fischer 344 rats Merrill J. EgorinTheodore F. LagattutaJulie L. Eiseman Original Article Pages: 7 - 19
Oral activity and pharmacokinetics of 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in mice Liangli ZhaoPhilip KestellBruce C. Baguley Original Article Pages: 20 - 26
Phenylbutyrate-induced apoptosis is associated with inactivation of NF-κB IN HT-29 colon cancer cells Rena FeinmanKevin O. ClarkeLawrence E. Harrison Original Article Pages: 27 - 34
Enhanced antitumor activities of TZT-1027 against TNF-α or IL-6 secreting Lewis lung carcinoma in vivo Tsugitaka NatsumeYasuhiro KohKazuto Nishio Original Article Pages: 35 - 47
Blood and plasma pharmacokinetics of vinorelbine in elderly patients with advanced metastatic cancer Amélie GauvinFrédéric PinguetFrançoise Bressolle Original Article Pages: 48 - 56
Pharmacokinetics of Bcl-2 antisense oligonucleotide (G3139) combined with doxorubicin in SCID mice bearing human breast cancer solid tumor xenografts Daniel E. Lopes de MenezesLawrence D. Mayer Original Article Pages: 57 - 68
Antiangiogenic effects of a protein kinase Cβ-selective small molecule Beverly A. TeicherEnrique AlvarezMargaret M. Faul Original Article Pages: 69 - 77
Doxorubicin-induced apoptosis and chemosensitivity in hepatoma cell lines Terence LeeTracy LauIrene Ng Original Article Pages: 78 - 86
Atypical pharmacokinetics and excretion of new platinum analogues in rodents Lorraine K. WebsterAndrew G. EllisGlen B. Deacon Original Article Pages: 87 - 92